No Barrier Raises $2.7M in Seed Round to Advance AI Medical Interpreter
No Barrier

Get the full No Barrier company profile
Access contacts, investors, buying signals & more
No Barrier, a company focused on AI medical interpretation, has secured $2,700,000 in its latest funding round.
This investment will enable the company to further develop its platform designed to address critical language barriers within healthcare settings.
The capital infusion underscores growing investor confidence in technological solutions aimed at improving patient care and operational efficiency.
No Barrier provides an AI medical interpreter specifically for hospitals, clinics, and healthcare networks.
Its platform delivers real-time speech-to-speech interpretation, allowing providers and Limited English Proficiency (LEP) patients to communicate instantly.
This system is built to overcome challenges such as slow care, increased risk, and inflated costs associated with traditional human interpreters, which can be difficult to schedule, expensive, and inconsistent, particularly after hours.
The solution is HIPAA compliant, engineered for clinical accuracy, and incorporates safety controls, including easy escalation to a human interpreter when necessary.
The newly acquired funds will be strategically deployed to accelerate No Barrier's product development, expand its market reach across healthcare providers, and scale its operational infrastructure.
These initiatives are aimed at enhancing the platform's capabilities and extending its availability to more medical facilities seeking 24/7 on-demand interpreting services across 30+ languages and dialects.
The company's focus remains on delivering consistent quality and operational efficiency, thereby reducing interpreter spend and shortening encounter times.
Looking ahead, this funding positions No Barrier to significantly advance its mission of improving healthcare language access while simultaneously lowering costs for healthcare organizations.
The company plans to leverage this investment to become a leading solution for compliant language access at the point of care, aligning with healthcare providers' ongoing roadmaps for digital transformation and patient experience enhancement.
Buying Signals & Intent
Our AI suggests No Barrier may be interested in:
Unlock GTM Signals
Discover No Barrier's tech stack and active buying intent signals.
View GTM SignalsTrusted by 200+ sales professionals
Unlock Investor Data
See who invested in No Barrier and connect with key investment contacts.
Unlock InvestorsTrusted by 200+ sales professionals
Unlock Key Decision-Makers
Get direct access to the key decision-makers at No Barrier.
Unlock Decision-MakersTrusted by 200+ sales professionals